M28 Capital Management LP
STAMFORD, CT · CIK 1807489 · 13F filing filed 2022-08-12
Exempt reporting adviser since 2026 · limited partnership
- Private funds3 (1 hedge) · $113.2m gross assets
- Websitem28capital.com
- Form ADV · 2026-04-22SEC adviser record
- Legal entityM28 CAPITAL MANAGEMENT LP (US)
- Kindhedge funds, venture, futures
- Others nearbyStamford, CT
As an employer
- Offices in1 country
- Private fundshedge 1, venture capital 2
$89.2m
reported value
-18.0% vs Q1 2022
13positions
96.5%in top 10
0 new
1 added
3 reduced
0 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| WAVE LIFE SCIENCES LTD 96663EUR | $26.9m30.17% | Added +2.4m |
| INVIVYD INC IVVD | $21.0m23.53% | Unchanged |
| ROCKET PHARMACEUTICALS INC RCKT | $9.9m11.04% | Unchanged |
| STOKE THERAPEUTICS INC STOK | $7.0m7.81% | Unchanged |
| BRIDGEBIO PHARMA INC BBIO | $4.2m4.75% | Unchanged |
| CURIS INC COM NEW | $4.2m4.68% | Unchanged |
| MIRATI THERAPEUTICS INC MRTX | $4.1m4.61% | Reduced -21.7k |
| TG THERAPEUTICS INC TGTX | $3.1m3.46% | Reduced -321.7k |
| LEAP THERAPEUTICS INC LPTX | $3.1m3.43% | Unchanged |
| VERVE THERAPEUTICS INC COM | $2.7m3.06% | Unchanged |
| ATARA BIOTHERAPEUTICS INC COM | $2.1m2.35% | Reduced -120.1k |
| PROQR THRAPEUTICS N V PRQR | $779.0k0.87% | Unchanged |
| NEXIMMUNE INC COM | $215.0k0.24% | Unchanged |